- Location
STEMI
"-
Miracor Medical Systems Announced 30 Patients Have Been Treated with PICSO System
Nov 14, 2013Austria-based Miracor Medical Systems has announced that 30 patients have been successfully treated with no device-related adverse events using its PICSO (pressure-controlled intermittent coronary sinus occlusion) system designed to improve ...
Tags: PICSO System, Medical Systems
-
MGuard Embolic Protection Stent Is Launched by InspireMD
Apr 25, 2013InspireMD has received approval for its investigational device exemption (IDE) application from the US Food and Drug Administration (FDA) to initiate MASTER II clinical study of its MGuard embolic protection stent (EPS). The CE-marked ...
Tags: InspireMD, Protection Stent Study
-
Velomedix Therapeutic Hypothermia System Pilot Study Is Approved by Health Canada
Jan 11, 2013Velomedix has obtained regulatory approval from Health Canada for its pilot study of Velomedix rapid therapeutic hypothermia system, designed for use in patients with acute myocardial infarctions (AMIs or heart attacks). The Velomedix ...
Tags: Velomedix, egulatory approval, Health Canada
-
Cellaegis Devices Has Obtained Health Canada's ITA to Initiate a Pilot Clinical Trial
Dec 18, 2012CellAegis Devices has obtained Health Canada's investigational testing (ITA) approval to initiate a pilot clinical trial of its noninvasive autoRIC device for remote ischemic conditioning (RIC). The CE-marked device is placed around ...
Tags: Health Canada, ITA, clinical trial, RIC
-
Miracor Treats First Three STEMI Patients Using PICSO System For 90 Minutes
Dec 17, 2012Miracor Medical Systems has treated first three ST segment elevation myocardial infarction (STEMI) patients, enrolled in the Prepare Ramses study, using its pressure-controlled intermittent coronary sinus occlusion (PICSO) impulse system ...
-
FDA Grants IDE to STENTYS to Conduct a Pivotal APPOSITION V Clinical Study
Dec 17, 2012The US Food and Drug Administration (FDA) has granted investigational device exemption (IDE) to STENTYS to conduct a pivotal APPOSITION V clinical study for its Self-Apposing stent. The Self-Apposing technology, which adapts vessels with ...
